Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Executive Management

Developing and introducing new medical products requires the experience of Big Pharma and the agility of New Pharma decision-making. All members of the ThromboGenics Executive Committee and broader Operations Management Team have acquired both throughout past experiences.

Broad expertise

Long-term company success is ensured by our leadership team’s expertise and experience in research, clinical development, commercialization, and financing. Whereas the Executive Committee will set the company’s vision and strategy, the broader Operations Management Team is responsible for planning and overseeing the execution of this strategy.

ThromboGenics Operations Management Team:

Andy De Deene*, Claude Sander*, Dominique Vanfleteren*, Grégoire Franoux, Isabelle Decoster, Jean Feyen*, Lionel Moro, Marc Denayer, Ove Pedersen, Patrik De Haes*, Paul Howes*, Rosemarie Corrigan, Wouter Piepers, Zoe Heineman

* Executive Committee member


Dr Patrik De Haes – Chief Executive Officer
Dr Patrik De Haes has over 25 years of experience in the global healthcare industry, covering product development, marketing and general management. Before joining ThromboGenics as CEO in 2008, Patrik was Head of Roche’s Global Insulin Infusion business. Prior to this, he was President and CEO of Disetronic Medical Systems Inc, a medical device company based in Minneapolis, USA. He also led the global development and commercialization of the first biotech product at Sandoz Pharma (now Novartis) in Switzerland. Patrik holds a degree in Medicine from the University of Leuven. 


Dominique Vanfleteren – Chief Financial Officer
Dominique Vanfleteren has over 25 years of experience in senior finance, operational, control and reporting roles within quoted international biopharmaceutical companies. Before joining ThromboGenics, Dominique spent 12 years at UCB, a global biopharmaceutical company, where he held a number of international managerial finance positions, the latest being the CFO of UCB’s Asia Pacific Operations, operating from Brussels and Shanghai. Prior to joining UCB, Dominique worked for GSK during 16 years. He held a number of senior finance positions in Brussels and London, his latest being Finance Director of GSK’s Diversified Healthcare Services Europe. Dominique holds a Bachelor Degree in Civil Engineering, and a Master Degree in Applied Economics (UCL).